Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 139

1.

Evaluating patient values and preferences for thromboprophylaxis decision making during pregnancy: a study protocol.

Alonso-Coello P, Ebrahim S, Guyatt GH, Tikkinen KA, Eckman MH, Neumann I, McDonald SD, Akl EA, Bates SM.

BMC Pregnancy Childbirth. 2012 May 30;12:40. doi: 10.1186/1471-2393-12-40.

2.

Women's values and preferences and health state valuations for thromboprophylaxis during pregnancy: A cross-sectional interview.

Bates SM, Alonso-Coello P, Tikkinen KA, Ebrahim S, Lopes LC, McDonald SD, Zhou Q, Akl EA, Neumann I, Jacobsen AF, Zhang Y, Santamaría A, Annichino-Bizzacchi JM, Sandset PM, Bitar W, Eckman MH, Guyatt GH.

Thromb Res. 2016 Apr;140:22-9.

PMID:
27500301
3.

Women's values and preferences for thromboprophylaxis during pregnancy: a comparison of direct-choice and decision analysis using patient specific utilities.

Eckman MH, Alonso-Coello P, Guyatt GH, Ebrahim S, Tikkinen KA, Lopes LC, Neumann I, McDonald SD, Zhang Y, Zhou Q, Akl EA, Jacobsen AF, Santamaría A, Annichino-Bizzacchi JM, Bitar W, Sandset PM, Bates SM.

Thromb Res. 2015 Aug;136(2):341-7. doi: 10.1016/j.thromres.2015.05.020. Epub 2015 May 22.

4.

Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

Bates SM, Greer IA, Pabinger I, Sofaer S, Hirsh J.

Chest. 2008 Jun;133(6 Suppl):844S-886S. doi: 10.1378/chest.08-0761.

PMID:
18574280
5.

Low-molecular-weight heparin to prevent recurrent venous thromboembolism in pregnancy: Rationale and design of the Highlow study, a randomised trial of two doses.

Bleker SM, Buchmüller A, Chauleur C, Ní Áinle F, Donnelly J, Verhamme P, Jacobsen AF, Ganzevoort W, Prins M, Beyer-Westendorf J, DeSancho M, Konstantinides S, Pabinger I, Rodger M, Decousus H, Middeldorp S.

Thromb Res. 2016 Aug;144:62-8. doi: 10.1016/j.thromres.2016.06.001. Epub 2016 Jun 3.

PMID:
27289488
6.

The incidence and risk factors of recurrent venous thromboembolism during pregnancy.

Galambosi PJ, Ulander VM, Kaaja RJ.

Thromb Res. 2014 Aug;134(2):240-5. doi: 10.1016/j.thromres.2014.04.026. Epub 2014 May 2.

PMID:
24835671
7.

Prophylaxis for venous thromboembolic disease in pregnancy and the early postnatal period.

Bain E, Wilson A, Tooher R, Gates S, Davis LJ, Middleton P.

Cochrane Database Syst Rev. 2014 Feb 11;(2):CD001689. doi: 10.1002/14651858.CD001689.pub3. Review.

PMID:
24519568
8.

Pregnancy after catheter-directed thrombolysis for acute iliofemoral deep venous thrombosis.

Jørgensen M, Broholm R, Bækgaard N.

Phlebology. 2013 Mar;28 Suppl 1:34-8. doi: 10.1177/0268355513477286.

PMID:
23482532
9.

Prophylaxis with low-dose low-molecular-weight heparin during pregnancy and postpartum: is it effective?

Roeters van Lennep JE, Meijer E, Klumper FJ, Middeldorp JM, Bloemenkamp KW, Middeldorp S.

J Thromb Haemost. 2011 Mar;9(3):473-80. doi: 10.1111/j.1538-7836.2011.04186.x.

10.

[Thrombophilia, preeclampsia and other pregnancy complications].

Vucić N, Frleta M, Petrović D, Ostojić V.

Acta Med Croatica. 2009 Oct;63(4):297-305. Review. Croatian.

PMID:
20034330
11.

Assessing, preventing, and treating venous thromboembolism: evidence-based approaches.

Nutescu EA.

Am J Health Syst Pharm. 2007 Jun 1;64(11 Suppl 7):S5-13. Review.

PMID:
17519445
12.

[Clinical analysis of 20 pregnant women with venous thromboembolic disease].

Sun P, Dong DN.

Zhonghua Fu Chan Ke Za Zhi. 2011 Dec;46(12):911-6. Chinese.

PMID:
22333281
13.

[Thromboprophylaxis during pregnancy and the puerperium: highlights from current guidelines].

Rath W.

Z Geburtshilfe Neonatol. 2010 Dec;214(6):217-28. doi: 10.1055/s-0030-1269861. Epub 2011 Jan 4. Review. German.

PMID:
21207321
14.

Venous thromboembolism in cancer patients.

Deng A, Galanis T, Graham MG.

Hosp Pract (1995). 2014 Dec;42(5):24-33. doi: 10.3810/hp.2014.12.1156. Review.

PMID:
25485915
15.

Prolonged thromboprophylaxis with low molecular weight heparin for abdominal or pelvic surgery.

Rasmussen MS, Jørgensen LN, Wille-Jørgensen P.

Cochrane Database Syst Rev. 2009 Jan 21;(1):CD004318. doi: 10.1002/14651858.CD004318.pub2. Review.

PMID:
19160234
16.

Cost-effectiveness of prophylactic low molecular weight heparin in pregnant women with a prior history of venous thromboembolism.

Johnston JA, Brill-Edwards P, Ginsberg JS, Pauker SG, Eckman MH.

Am J Med. 2005 May;118(5):503-14. Review.

PMID:
15866253
17.

[Pharmacological Thromboprophylaxis during Pregnancy and the Puerperium: Recommendations from Current Guidelines and their Critical Comparison].

Rath W, Tsikouras P, von Tempelhoff GF.

Z Geburtshilfe Neonatol. 2016 Jun;220(3):95-105. doi: 10.1055/s-0042-106654. Epub 2016 Jun 17. Review. German.

PMID:
27315397
18.

Thromboprophylaxis with low-molecular-weight heparin after cesarean delivery.

Blondon M, Perrier A, Nendaz M, Righini M, Boehlen F, Boulvain M, De Moerloose P.

Thromb Haemost. 2010 Jan;103(1):129-37. doi: 10.1160/TH09-06-0349. Epub 2009 Oct 26.

PMID:
20062923
19.

International clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer.

Farge D, Debourdeau P, Beckers M, Baglin C, Bauersachs RM, Brenner B, Brilhante D, Falanga A, Gerotzafias GT, Haim N, Kakkar AK, Khorana AA, Lecumberri R, Mandala M, Marty M, Monreal M, Mousa SA, Noble S, Pabinger I, Prandoni P, Prins MH, Qari MH, Streiff MB, Syrigos K, Bounameaux H, Büller HR.

J Thromb Haemost. 2013 Jan;11(1):56-70. doi: 10.1111/jth.12070. Review.

20.

The management of thrombosis in pregnancy: role of low-molecular-weight heparin.

Kher A, Bauersachs R, Nielsen JD.

Thromb Haemost. 2007 Apr;97(4):505-13. Review.

PMID:
17393011

Supplemental Content

Support Center